Trending

atrial fibrillation

Lixiana hits the mark in catheter ablation trial

Lixiana hits the mark in catheter ablation trial

Daiichi Sankyo’s Lixiana was a late entrant to the novel oral anticoagulant (NOAC) category, but the Japanese drugmaker

X

Lixiana hits the mark in catheter ablation trial

https://pharmaphorum.com/news/lixiana-hits-the-mark-in-catheter-ablation-trial/

Apple Watch shows early promise in AFib diagnosis

Apple Watch shows early promise in AFib diagnosis

A large-scale study has provided some evidence that the Apple Watch could be used to detect atrial fibrillation

X

Apple Watch shows early promise in AFib diagnosis

https://pharmaphorum.com/news/apple-watch-shows-early-promise-in-afib-diagnosis/

J&J partners with Apple for ECG monitoring project

J&J partners with Apple for ECG monitoring project

Apple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG)

X

J&J partners with Apple for ECG monitoring project

https://pharmaphorum.com/news/jj-partners-with-apple-for-ecg-monitoring-project/

FDA approves first smartphone compatible heart monitor

FDA approves first smartphone compatible heart monitor

Cardiac Rx ICM now available to remotely monitor patient heart health.

X

FDA approves first smartphone compatible heart monitor

https://pharmaphorum.com/news/abbott-smartphone-heart-monitor-fda/

Crowdsourcing campaign looks to improve heart health diagnosis

Crowdsourcing campaign looks to improve heart health diagnosis

The Heart for Heart campaign aims to improve understanding about atrial fibrillation.

X

Crowdsourcing campaign looks to improve heart health diagnosis

https://pharmaphorum.com/news/crowdsourcing-heart-health-diagnosis/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com